SuperworthCSW Industrials CSW
- Market cap
- $4.8B
- PE
- 40.6×
- 10y median 34.7×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 4.1×
- EV/EBIT
- 26.0×
- Revenue, 12 months
- $1.2B
- +28% on a year ago
- Net margin
- 10.3%
- Free cash flow yield
- 3.0%
CSW Industrials trades at 40.6× trailing earnings, pricier than 70% of the last ten years. Revenue was $1.2B over the last twelve months, up 28% on a year earlier with a 10% net margin.
Charts
Financials
| Income statement | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $203.7M+7% | $175M+2% | $210.9M+8% | $226.2M+11% | $227.9M+12% | $193.6M+11% | $230.5M+9% | $263.6M+17% | $277M+22% | $233M+20% | $309M+34% | $350.6M+33% | |
| Cost of revenue | $112.7M+2% | $101M−4% | $117.2M+6% | $118.8M+7% | $124M+10% | $113.5M+12% | $128.7M+10% | $148.2M+25% | $157.8M+27% | $140.5M+24% | $182.3M+42% | $193.3M+30% |
| Gross profit | $91M+13% | $74M+12% | $93.6M+10% | $107.4M+17% | $103.9M+14% | $80.1M+8% | $101.9M+9% | $115.4M+8% | $119.2M+15% | $92.4M+15% | $126.6M+24% | $157.4M+36% |
| R&D | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| SG&A | $49M+8% | $46.4M+9% | $49.3M+8% | $52.4M+12% | $52.4M+7% | $50.5M+9% | $56.8M+15% | $60.6M+16% | $62.4M+19% | $75.1M+49% | $71.4M+26% | $77.5M+28% |
| $42M+19% | $27.6M+19% | $44.3M+12% | $55.1M+22% | $51.5M+23% | $29.6M+7% | $45M+2% | $54.9M−0% | $56.8M+10% | $17.3M−41% | $39.5M−12% | $79.9M+46% | |
| Interest expense | $3.3M+6% | $2.8M−34% | $2.6M−36% | $2.5M−37% | $1.3M−59% | −$2M | −$1.6M | $1M−59% | $1.3M−2% | $8.1M | $11.8M | $12.7M+1146% |
| Pre-tax income | $40.6M+26% | $16.4M−10% | $42M+16% | $52.8M+27% | $49.5M+22% | $31.3M+91% | $46.5M+11% | $54.4M+3% | $55.5M+12% | $7.9M−75% | $27.8M−40% | $66.9M+23% |
| $10.4M+31% | $7.1M+165% | $10M+10% | $13.9M+33% | $12.9M+24% | $4.3M−39% | $11.5M+15% | $13.2M−5% | $14.7M+14% | −$2.7M | $7.5M−34% | $17.1M+30% | |
| Net income | $30.1M+24% | $9.2M−41% | $31.8M+17% | $38.6M+26% | $36.1M+20% | $26.9M+192% | $35.1M+10% | $40.9M+6% | $40.7M+13% | $10.3M−62% | $20.2M−42% | $49.8M+22% |
| $1.93+23% | $0.59−42% | $2.04+17% | $2.47+25% | $2.26+17% | $1.60+171% | $2.08+2% | $2.43−2% | $2.41+7% | $0.62−61% | $1.22−41% | $3.04+25% | |
| 15.6M+1% | 15.6M+1% | 15.6M+0% | 15.6M+0% | 15.9M+2% | 16.9M+8% | 16.9M+8% | 16.9M+8% | 16.8M+6% | 16.6M−1% | 16.5M−2% | 16.4M−3% |
Revenue: Q1 FY15: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY15: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY15: 6 months less the 3 months printed beside them.
R&D: Q1 FY15 and Q1 FY16: 6 months less the 3 months printed beside them.
SG&A: Q1 FY15: 6 months less the 3 months printed beside them.
Operating income: Q1 FY15 and Q1 FY16: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY15 and Q1 FY16: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY15: 6 months less the 3 months printed beside them.
Income tax: Q1 FY15 and Q1 FY16: 6 months less the 3 months printed beside them.
Net income: Q1 FY15: 6 months less the 3 months printed beside them.
EPS, diluted: 8 periods, Q1 FY15 to Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY15: share-days: the 6-month average less the second quarter's. 12 periods, Q4 FY15 to Q4 FY26: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Chemicals nearest CSW Industrials' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CSWCSW Industrials | $4.8B | 40.6× | 34.7× | 4.1× | +28% | 10.3% | |
| BCPCBalchem | $5.6B | 34.8× | 41.0× | 5.2× | +9% | 15.1% | |
| HXLHexcel | $6B | 40.0× | 35.9× | 3.0× | +5% | 7.8% | |
| CBTCabot | $3.8B | 20.8× | 14.4× | 1.0× | −5% | 5.2% | |
| AVNTAvient | $3.8B | 22.2× | 20.2× | 1.1× | +2% | 5.1% | |
| EMNEastman Chemical | $7.4B | 16.9× | 13.4× | 0.8× | −5% | 5.0% | |
| ESIElement Solutions | $8.1B | 44.9× | 30.1× | 2.6× | +27% | 5.7% | |
| WDFCWD 40 | $2.9B | 32.3× | 39.2× | 4.2× | +10% | 13.2% | |
| FULFuller H B | $2.7B | 13.8× | 22.9× | 0.8× | +1% | 5.6% | |
| IOSPInnospec | $2.4B | 20.1× | 22.3× | 1.3× | +3% | 6.6% | |
| NGVTIngevity | $2.4B | 47.4× | 19.9× | 2.1× | −4% | 4.7% | |
| Peer median | $3.8B | 27.3× | 22.6× | 1.7× | +3% | 5.6% |
More on CSW Industrials
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #5of 37Chemicals stocks with the fastest revenue growth
- #6of 37Chemicals stocks with the highest profit margins
- #8of 14Chemicals stocks with the fastest earnings growth
- #8of 13Chemicals stocks cheapest against their own PE history
Its groups
About
- Industry
- Chemicals
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .